Stocks and Investing
Stocks and Investing
Tue, January 5, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 4, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tim Lugo Upgraded (VTGN) to Buy on, Jan 4th, 2021
Tim Lugo of William Blair, Upgraded "Vistagen Therapeutics, Inc." (VTGN) to Buy on, Jan 4th, 2021.
Tim has made no other calls on VTGN in the last 4 months.
There is 1 other peer that has a rating on VTGN. Out of the 1 peers that are also analyzing VTGN, 0 agree with Tim's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tim
- Nathan Weinstein of "Aegis Capital" Initiated at Strong Buy and Held Target at $180 on, Thursday, October 8th, 2020
Contributing Sources